Analytical Data
-
Gene name
INHBE
- Application
-
Alternative Names
(Activin beta-E chain)
-
Species
Human
-
Source
E. coli
-
Tag
C- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P58166
-
Expression Region
237-350aa
-
Molecular Weight
19.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
INHBE, or Inhibin Beta E, is a member of the inhibin family of proteins, which play critical roles in reproductive health and endocrine regulation. Research on INHBE has gained attention due to its involvement in various physiological and pathological processes, including ovarian function, folliculogenesis, and the regulation of gonadotropin secretion. The protein is primarily expressed in ovarian tissues and has been found to have significant implications in fertility and reproductive disorders. Abnormal INHBE levels have been linked to conditions such as polycystic ovary syndrome (PCOS) and other hormonal imbalances. Recent studies have focused on the molecular mechanisms underlying INHBE's actions, its interactions with other hormonal pathways, and its potential as a biomarker for reproductive health. Additionally, as a recombinant protein, INHBE presents opportunities for therapeutic applications, such as in the development of fertility treatments and diagnostics. Understanding the structure, function, and regulation of INHBE can pave the way for innovative approaches to manage reproductive health issues and enhance fertility treatments, making it a significant focus within reproductive biology and endocrinology research.
